Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test Results

ABSTRACT Urinary catheters are widely used for hospitalized patients and are often associated with high rates of urinary tract infection. We evaluated in vitro the antiadherence activity of a novel antiseptic Gendine-coated urinary catheter against several multidrug-resistant bacteria. Gendine-coated urinary catheters were compared to silver hydrogel-coated Foley catheters and uncoated catheters. Bacterial biofilm formation was assessed by quantitative culture and scanning electron microscopy. These data were further correlated to an in vivo rabbit model. We challenged 31 rabbits daily for 4 days by inoculating the urethral meatus with 1.0 × 109 CFU streptomycin-resistant Escherichia coli per day. In vitro, Gendine-coated urinary catheters reduced the CFU of all organisms tested for biofilm adherence compared with uncoated and silver hydrogel-coated catheters (P < 0.004). Scanning electron microscopy analysis showed that a thick biofilm overlaid the control catheter and the silver hydrogel-coated catheters but not the Gendine-coated urinary catheter. Similar results were found with the rabbit model. Bacteriuria was present in 60% of rabbits with uncoated catheters and 71% of those with silver hydrogel-coated catheters (P < 0.01) but not in those with Gendine-coated urinary catheters. No rabbits with Gendine-coated urinary catheters had invasive bladder infections. Histopathologic assessment revealed no differences in toxicity or staining. Gendine-coated urinary catheters were more efficacious in preventing catheter-associated colonization and urinary tract infections than were silver hydrogel-coated Foley catheters and uncoated catheters.

[1]  W. A. Gillespie,et al.  LONG-TERM CATHETER DRAINAGE IN THE MALE. , 1965, British Journal of Urology.

[2]  K. Naber,et al.  Hospital-acquired urinary tract infections. , 2000, The Journal of hospital infection.

[3]  D. Classen,et al.  A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. , 1995, The American journal of medicine.

[4]  W. Stamm,et al.  Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. , 1990, The Journal of infectious diseases.

[5]  Public health focus: surveillance, prevention, and control of nosocomial infections. , 1992, MMWR. Morbidity and mortality weekly report.

[6]  Carlene A. Muto,et al.  A randomized crossover study of silver-coated urinary catheters in hospitalized patients. , 2000, Archives of internal medicine.

[7]  M. Ghannoum,et al.  Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.

[8]  J. Vazquez,et al.  Options for the Management of Mucosal Candidiasis in Patients with AIDS and HIV Infection , 1999, Pharmacotherapy.

[9]  W. A. Gillespie,et al.  THE DIAGNOSIS, EPIDEMIOLOGY AND CONTROL OF URINARY INFECTION IN UROLOGY AND GYNAECOLOGY , 1960, Journal of clinical pathology.

[10]  C. Kunin,et al.  Prevention of catheter-induced urinary-tract infections by sterile closed drainage. , 1967, The New England journal of medicine.

[11]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[12]  Sang Eun Lee,et al.  A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. , 2004, International journal of antimicrobial agents.

[13]  P. Scardino,et al.  Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. , 1999, Urology.

[14]  R. Sidwell,et al.  Handbook of Animal Models of Infection , 1999 .

[15]  C. W. Walter,et al.  Technical advances in the prevention of urinary tract infection. , 1962, The Journal of urology.

[16]  H. Ceri,et al.  Chapter 53 – The Rabbit Model of Catheter-associated Urinary Tract Infection , 1999 .

[17]  W. A. Gillespie,et al.  LONG‐TERM CATHETER DRAINAGE IN THE MALE1 , 1965 .

[18]  H. Ohkuni,et al.  Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. , 1995, The Journal of hospital infection.

[19]  W. A. Gillespie,et al.  Catheter drainage and infection in acute retention of urine. , 1960, Lancet.

[20]  W. A. Gillespie,et al.  Prevention of Urinary Infection in Gynaecology , 1964, British medical journal.

[21]  I. Raad,et al.  A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. , 2005, The Journal of antimicrobial chemotherapy.

[22]  J W Warren,et al.  Catheter-associated urinary tract infections. , 1997, International journal of antimicrobial agents.

[23]  S. Saint,et al.  The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. , 2000, Archives of internal medicine.

[24]  J. Fabry,et al.  Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. , 2000, The Journal of hospital infection.

[25]  H. Akiyama,et al.  Prophylaxis of indwelling urethral catheter infection: clinical experience with a modified Foley catheter and drainage system. , 1979, The Journal of urology.

[26]  M. Avidan,et al.  Catheter-associated urinary tract infections in intensive care units. , 2004, Microbes and infection.